Fibrinogen degradation products and factor VIII consumption in normal pregnancy and pre-eclampsia: role of the placenta

1980 ◽  
pp. 357-369 ◽  
Author(s):  
L. Matter ◽  
W. Page Faulk
1971 ◽  
Vol 26 (03) ◽  
pp. 523-525
Author(s):  
K Gibiński ◽  
B Lipiński ◽  
M Trusz-Gluza

SummaryWhile the native fibrinogen is not digested by the leucocyte proteases both the early and late FDP are digestible without any denaturating reagent. Thus, this reaction may occur in vivo indicating an unknown role of granulocytes in paracoagulation.


1972 ◽  
Vol 28 (03) ◽  
pp. 359-366 ◽  
Author(s):  
Włodzimierz Buczko ◽  
Konstanty Wiśniewski

SummaryThe role of fibrinolysis and FDP in the analgesic action of morphine in mice and rats was studied. It was shown that during activation of blood fibrinolysis, both the accumulation of morphine in the brain tissue of rats and the clinical effect of this drug were increased. Similar results were observed after morphine given simultaneously with FDP obtained in vitro. The data from the analysis of FDP carried out on Sephadex G-25 Fine columns suggest that only FDP of molecular weight of about 10,000 potentiate the action of morphine; smaller peptides decreased the action of this drug.


1990 ◽  
Vol 84 (3) ◽  
pp. 149-155 ◽  
Author(s):  
Masanori Saito ◽  
Hidesaku Asakura ◽  
Hiroshi Jokaji ◽  
Chika Uotanzi ◽  
Ichiro Kumabashiri ◽  
...  

1981 ◽  
Author(s):  
E Bertaglia ◽  
U Vertolli ◽  
V Pengo ◽  
B Baggio ◽  
C Tessarin ◽  
...  

To evaluate a possible interaction between coagulation factors, inflammation, and immunological disorders in the pathogenesis of glomerulonephritis (G.N.) factor VIII clotting activity (VIII:C), related-antigen (VIIIR:AG), urinary fibrinogen degradation products (F.D.P.) excretion and cyclic nucleotides (cAMP) in 21 patients affected by chronic G.N. with normal renal function, was investigated. These patients were followed-up for two years. For the assay of factor VIII:C, a factor VIII deficient plasma was used. Factor VIIIR:AG were assayed by rocket electroimmunodiffusion in agarose gel, urinary F.D.P. by Thrombo-Wellcotest and cAMP by radioimmunoassay. The same tests were performed in 25 healthy controls. Patients' clotting activity, measured at first admission, showed a significant decrease in comparison with the values obtained at the end of the follow-up period (t=-2.61 p<0.02).The clotting activity of the renal patients was lower than in controls (t=2.09 p<0.05). However, factor VIIIR:AG was significantly increased in the same patients. A significant direct correlation between the urinary excretion of cAMP and plasma concentration of factor VIIIR:AG (r=0.82 p<0.001) as well as between urinary F.D.P. and cAMP excretion (r=0.49 p<0.05) was found, when the patients were classified according to the morphological findings of the kidney biopsy. Most probably a circulating thrombin excess leads to consumption of factor VIII:C and promotes the extrusion of cyclic nucleotides from intracellular sites. The relationship found between factor VIIIR:AG, cAMP and F.D.P. besides showing a linkage between inflammation and coagulation, seems also to suggest a role for both factors in promoting a renal injury.


1966 ◽  
Vol 15 (03/04) ◽  
pp. 476-490 ◽  
Author(s):  
Kopeć Maria ◽  
A Budzyński ◽  
Jolanta Stachurska ◽  
Z Węgrzynowicz ◽  
E Kowalski

Summary1. Blood platelets can be aggregated by solutions of fibrinogen preparations of different origins. Fibrinogen degradation products (FDP) obtained by plasmin digestion do not aggregate platelets.2. Preparations of FDP added to platelet suspension inhibit aggregation induced by fibrinogen,.3. FDP when added to platelet suspensions, inhibit the release of adenine nucleotides induced by thrombin, connective tissue extract, kaolin or the contact factor.4. Platelet suspensions pretreated with SKPL loose partly the ability to release adenine nucleotides after the action of inducing agents.5. Washed platelet suspensions possess the capacity to adsorb fibrinogen and FDP, the latter being adsorbed in greater amounts and bound stronger than fibrinogen.6. An attempt was undertaken to explain the observed phenomena on the basis of a general view on the molecular mechanism of platelet function.It is postulated that fibrinogen is an integral part of the platelet surface and that it is one of the determinants of the platelet surface properties. Fibrinogen is necessary for platelet aggregation by ADP and for the adequate action of the agents which initiate metabolic changes and induce the release reaction. FDP act antagonistically to fibrinogen. They inhibit ADP aggregation as well as the access to the susceptible sites on. the surface of the platelet of the agents inducing release.


1979 ◽  
Vol 41 (03) ◽  
pp. 544-552 ◽  
Author(s):  
R P Herrmann ◽  
P E Bailey

SummaryUsing the chromogenic substrate, Tos-Gly-Pro-Arg-pNA-HCL (Chromozym TH, Boehringer Mannheim) plasma thrombin was estimated in six cases of envenomation by Australian elapid snakes. All patients manifested findings chracteristic of defibrination due to envenomation by these snakes. Fibrin-fibrinogen degradation products were grossly elevated, as was plasma thrombin in all cases.Following treatment with antivenene, all abnormal coagulation parameters returned rapidly towards normal by 24 hours and plasma thrombin disappeared.


Sign in / Sign up

Export Citation Format

Share Document